NewGenIvf Group EBITDA 2023-2024 | NIVF

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

NewGenIvf Group ebitda from 2023 to 2024. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

NewGenIvf Group ebitda from 2023 to 2024. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.

Related Stocks
Company Name	Market Cap
Danaher (DHR)	$146.6B
CVS Health (CVS)	$81.9B
Elevance Health (ELV)	$77B
Cencora (COR)	$57.2B
DiDi Global (DIDIY)	$24.2B
Natera (NTRA)	$21.9B
Labcorp Holdings (LH)	$20.9B
BioMerieux (BMXMF)	$16.9B
EUROFINS SCIENT (ERFSF)	$13.7B
CochLear (CHEOY)	$12.8B
Solventum (SOLV)	$12.8B
ICON (ICLR)	$12.2B
Revvity (RVTY)	$12B
Viatris (VTRS)	$10.7B
Medpace Holdings (MEDP)	$9.3B
Avantor (AVTR)	$9.3B
Sonic Healthcare (SKHHY)	$8.9B
HealthEquity (HQY)	$8.2B
Charles River Laboratories (CRL)	$7.8B
Caris Life Sciences,�Inc (CAI)	$6.7B
Amplifon S.p.A (AMFPF)	$5.4B
Bausch + Lomb (BLCO)	$4.9B
BrightSpring Health Services (BTSG)	$3.6B
Sotera Health (SHC)	$3.3B
Surgery Partners (SGRY)	$2.8B
Alignment Healthcare (ALHC)	$2.6B
Organon (OGN)	$2.6B
Concentras Parent (CON)	$2.6B
GeneDx Holdings (WGS)	$2.4B
Ardent Health (ARDT)	$2B